financetom
Business
financetom
/
Business
/
Dyne Therapeutics Insider Sold Shares Worth $1,398,347, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dyne Therapeutics Insider Sold Shares Worth $1,398,347, According to a Recent SEC Filing
Mar 5, 2024 2:33 PM

05:11 PM EST, 03/05/2024 (MT Newswires) -- Jason P Rhodes, Director, on March 01, 2024, sold 46,534 shares in Dyne Therapeutics ( DYN ) for $1,398,347. Following the Form 4 filing with the SEC, Rhodes has control over a total of 6,545,479 shares of the company, with 6,545,479 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000141588924006766/xslF345X03/form4-03052024_100311.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marwest Apartment REIT Swings to Q2 Net Loss
Marwest Apartment REIT Swings to Q2 Net Loss
Aug 20, 2025
07:48 AM EDT, 08/20/2025 (MT Newswires) -- Marwest Apartment Real Estate Investment Trust (MAR-UN.V) said overnight Tuesday that it swung to a net loss in the second quarter. The REIT reported a net loss of $10,826 for the three months ended June 30, reversing the year-ago net income of $2.5 million. Revenue from investment properties remained steady at $2.6 million...
Exclusive-China considering yuan-backed stablecoins to boost global currency usage, sources say
Exclusive-China considering yuan-backed stablecoins to boost global currency usage, sources say
Aug 20, 2025
(Reuters) -China is considering allowing the usage of yuan-backed stablecoins for the first time to boost wider adoption of its currency globally, sources familiar with the matter said, in a major reversal of its stance towards digital assets. The State Council - China's cabinet - will review and possibly approve a roadmap later this month for the greater usage of...
Kingsoft Cloud's Q2 Loss Widens, Revenue Rises
Kingsoft Cloud's Q2 Loss Widens, Revenue Rises
Aug 20, 2025
07:54 AM EDT, 08/20/2025 (MT Newswires) -- Kingsoft Cloud ( KC ) reported Wednesday a Q2 net loss of 0.11 Chinese renminbi ($0.01) per diluted share, compared with a loss of $0.10 renminbi a year earlier. Three analysts polled by FactSet expected a loss of 1.23 renminbi. Revenue for the quarter ended June 30 was 2.35 billion renminbi, up from...
Jazz Pharmaceuticals Receives Global Rights to Saniona's Epilepsy Drug in More Than $1 Billion Deal
Jazz Pharmaceuticals Receives Global Rights to Saniona's Epilepsy Drug in More Than $1 Billion Deal
Aug 20, 2025
07:53 AM EDT, 08/20/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) has obtained exclusive worldwide rights to develop and commercialize Saniona's experimental epilepsy drug, SAN2355, the companies said Wednesday. Saniona will receive an upfront payment of $42.5 million, with potential additional payments totaling over $1 billion, including development, regulatory, and commercial milestone payments, as well as royalties on future...
Copyright 2023-2026 - www.financetom.com All Rights Reserved